Translation initiation complex

The **translation initiation complex** refers to a dynamic macromolecular assembly of ribosomal subunits, initiator tRNA, mRNA, and multiple eukaryotic initiation factors (eIFs) that mediates the beginning of protein synthesis in eukaryotic cells[1][2][4]. The assembly begins with a 43S pre-initiation complex (composed of the 40S ribosomal subunit, eIF1, eIF1A, eIF3, eIF5, and the ternary complex of eIF2-GTP-initiator tRNA), which is recruited to the mRNA 5′ end via interaction with the cap-binding eIF4F complex (eIF4E, eIF4A, eIF4G) and poly(A)-binding protein PABP[2][4]. The resulting 48S initiation complex scans the mRNA to identify the start codon, whereupon further factor exchange, GTP hydrolysis, and joining of the 60S ribosomal subunit finalize formation of the elongation-competent 80S ribosome[1][2][4]. Complex regulation by initiation factors allows tight control of translation rates and fidelity, and dysregulation (e.g., overexpression of eIF4E or altered eIF2 signaling) links aberrant initiation to cancer, neurodegeneration, and viral infection[2][3]. Drugs generally do not target the entire translation initiation complex, but small molecule modulators of individual factors (e.g., eIF4E, eIF4A) are under active investigation as anti-cancer agents. Because the "translation initiation complex" is not a single protein, but a dynamic assembly, the term is imprecise as a conventional drug target and instead refers to complexes such as "48S initiation complex" or "43S pre-initiation complex."[2][4]

Inhibition or modulation of specific initiation factors within the complex (e.g., eIF4E, eIF4A inhibitors)